BRIEF-Entrada Therapeutics Inc On Track To Report Elevate-44-201 Cohort 1 Data In Q2 2026, Cohort 2 Data By End Of Year

-2.23%

Entrada Therapeutics Inc

TRDA

12.69

-2.23%

Feb 17 (Reuters) - Entrada Therapeutics Inc TRDA.O:

ENTRADA THERAPEUTICS INC - ON TRACK TO REPORT ELEVATE-44-201 COHORT 1 DATA IN Q2 2026, COHORT 2 DATA BY END OF YEAR
ENTRADA THERAPEUTICS INC - INTENDS TO OPEN EXPANSION COHORT LATER THIS YEAR IN ELEVATE-44-201 STUDY

Source text: ID:nGNX25yJ7q

Further company coverage: TRDA.O

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.